## BACKGROUND. To understand better the natural history and biology of prostate carcinoma occurring in Japanese patients, the authors attempted to define changes with time in prostate specific antigen (PSA) measurements in 48 men with clinically resectable T1-T3 nonmetastatic disease. ## METHODS.
Tissue concentrations of tissue polypeptide antigen (TPA) and prostatic specific antigen (PSA) in 42 patients with prostatic carcinoma
✍ Scribed by Mirtha Grande; Kjell Carlström; Barbro Lundh Rozell; Peter Eneroth; Reinhard Stege; Åke Pousette
- Publisher
- John Wiley and Sons
- Year
- 2000
- Tongue
- English
- Weight
- 203 KB
- Volume
- 45
- Category
- Article
- ISSN
- 0270-4137
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
Our aim was to evaluate the clinical usefulness of serum concentrations of squamous-cell carcinoma antigen (SCC-Ag) and tissue polypeptide antigen (TPA) in the follow-up of patients with vulvar cancer. We measured SCC-Ag and TPA in 480 serum samples of 82 patients with squamous-cell vulvar cancer. R
Measurement of serum concentrations of tissue polypeptide-specific Antigen (TPS) has been demonstrated to be useful in diagnosis and monitoring of adult epithelial tumors. So far, no data have been available on normal or pathologic TPS values in children. Therefore, the present study was designed to
The volume of the transition zone was also measured by TRUS in 134 patients.
BACKGROUND. The present study evaluated monthly measurements of free and total prostate-specific antigen (PSA), and the tumor proliferation markers tissue polypeptide-specific antigen (TPS) and cytokeratin fragment 21-1 (CYFRA 21-1) in patients with advanced prostate cancer receiving intermittent an
This retrospective study includes 425 serological examinations of 40 patients with epithelial ovarian cancer and 356 serological examinations of 33 patients with squamous cell cervical cancer. The serum levels of the tumor markers tissue polypeptide specific antigen (TPS), carbohydrate antigen 125 (